Myb and Ets proteins are candidate regulators of c-kit expression in human hematopoietic cells

Blood

Volumn 91, Issue 6, 1998, Pages 1934-1946

  Ratajczak, Mariusz Z ^b   Perrotti, Danilo ^b   Melotti, Paola ^b   Powzaniuk, Mark ^b   Calabretta, Bruno ^b   Onodera, Kuzufumi ^b   Kregenow, David A ^b   Machalinski, Bogdan ^b   Gewirtz, Alan M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; DNA FLANKING REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

EID: 0032521541     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.1934.1934_1934_1946     Document Type: Article

References (55)

1. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341, 1987
2. Huang E, Nocka K, Beier DR, Chu TY, Buck J, Lahm HW, Wellner D, Leder P, Besmer P: The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 63:225, 1990
3. Williams DE, Eisenman J, Baird A, Rauch C, Van Ness K, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167, 1990
4. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Satyagal VN, Tung W, Bosselman RA, Mendiaz EA, Largley KE: Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63:213, 1990
5. Zsebo KM, Wypych J, McNiece IK, Lu HS, Smith KA, Karkare SB, Sachdev RK, Yuschenkoff VN, Birkett NC, Williams LR, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu R-Y, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Takeihi T, Cattanach BM, Galli SJ, Suggs SV: Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver-conditioned medium. Cell 63:195, 1990
6. Geissler EN, McFarland EC, Russell ES: Analysis of pleiotropism at the dominant white-spotting (W) locus of the house mouse: a description of ten new W alleles. Genetics 97:337, 1981
7. Hong DS, Beckham C, Huss R, Lee JW, Hockenbery D, Ledbetter JA, Deeg HJ: Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand. Blood 86:3341, 1995
8. + marrow cells. Blood 86:2161, 1995
9. Metcalf D, Nicola NA: Direct proliferative actions of stem cell factor on murine bone marrow cells in vitro: Effects of combination with colony-stimulating factors. Proc Natl Acad Sci USA 88:6239, 1991
10. Kinashi T, Springer TA: Adhesion molecules in hematopoietic cells. Blood Cells 20:25, 1994
11. Papayannopoulou T, Brice M, Broudy VC, Zsebo KM: Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile. Blood 78:1403, 1991
12. Ratajczak MZ, Luger SM, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM: Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89:1710, 1992
13. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
14. Wu H, Klingmuller U, Besmer P, Lodish HF: Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242, 1995
15. Russell ES: Hereditary anemias of the mouse: A review for geneticists. Adv Genet 20:357, 1979
16. Fleischman RA, Saltman DL, Stastny V, Zneimer S: Deletion of the c-kit protooncogene in the human developmental defect piebald trait. Proc Natl Acad Sci USA 88:10885, 1991
17. Giebel LB, Spritz RA: Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci USA 88:8696, 1991
18. Murohashi I, Endoh K, Feng M, Yoshida K, Hirota H, Yoshida S, Jinnai I, Bessho M, Hirashima K: Roles of stem cell factor in the in vitro growth of blast clonogenic cells from patients with acute myeloblastic leukemia. J Interferon Cytokine Res 15:829, 1995
19. Dubois CM, Ruscetti FW, Stankova J, Keller JR: Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 83:3138, 1994
20. Heinrich MC, Dooley DC, Keeble WW: Transforming growth factor beta 1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood 85:1769, 1995
21. Rusten LS, Smeland EB, Jacobsen FW, Lien E, Lesslauer W, Loetscher H, Dubois CM, Jacobsen SE: Tumor necrosis factor-alpha inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of p55 and p75 tumor necrosis factor receptors. J Clin Invest 94:165, 1994
22. + cells via p55 TNF alpha receptors. Blood 84:2506, 1994
23. Jacobsen FW, Dubois CM, Rusten LS, Veiby OP, Jacobsen SE: Inhibition of stem cell factor-induced proliferation of primitive murine hematopoietic progenitor cells signaled through the 75-kilodalton tumor necrosis factor receptor. Regulation of c-kit and p53 expression. J Immunol 154:3732, 1995
24. Melotti P, Calabretta B: Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. Blood 87:2221, 1996
25. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJ, Jr., Potter SS: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677, 1991
26. Melotti P, Calabretta B: The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. Proc Natl Acad Sci USA 93:5313, 1996
27. Vandenbark GR, Chen Y, Friday E, Pavlik K, Anthony B, deCastro C, Kaufman RE: Complex regulation of human c-kit transcription by promoter repressors, activators, and specific myb elements. Cell Growth Differ 7:1383, 1996
28. Melotti P, Calabretta B: Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J Biol Chem 269:25303, 1994
29. Melotti P, Ku DH, Calabretta B: Regulation of the expression of the hematopoietic stem cell antigen CD34: Role of c-myb. J Exp Med 179:1023, 1994
30. Siu G, Wurster AL, Lipsick JS, Hedrick SM: Expression of the CD4 gene requires a Myb transcription factor. Mol Cell Biol 12:1592, 1992
31. Dudek H, Tantravahi RV, Rao VN, Reddy ES, Reddy EP: Myb and Ets proteins cooperate in transcriptional activation of the mim-1 promoter. Proc Natl Acad Sci USA 89:1291, 1992
32. Sala A, Bellon T, Melotti P, Peschle C, Calabretta B: Inhibition of erythro-myeloid differentiation by constitutive expression of a DNA binding-deficient c-myb mutant: Implication for c-myb function. Blood 86:3404, 1995
33. Henthorn PS, Raducha M, Kadesch T, Weiss MJ, Harris H: Sequence and characterization of the human intestinal alkaline phosphatasc gene. J Biol Chem 263:12011, 1988
34. Perrotti D, Bellon T, Trotta R, Martinez R, Calabretta B: A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. Blood 88:3336, 1996
35. Ku DH, Wen SC, Engelhard A, Nicolaides NC, Lipson KE, Marino TA, Calabretta B: c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene [published erratum appears in J Biol Chem 268:13010, 1993]. J Biol Chem 268:2255, 1993
36. Ma XP, Calabretta B: DNA binding and transactivation activity of A-myb, a c-myb-related gene. Cancer Res 54:6512, 1994
37. Wen SC, Ku DH, De Luca A, Claudio PP, Giordano A, Calabretta B: ets-2 regulates cdc2 kinase activity in mammalian cells: coordinated expression of cdc2 and cyclin A. Exp Cell Res 217:8, 1995
38. Giebel LB, Strunk KM, Holmes SA, Spritz RA: Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 7:2207, 1992
39. Yamamoto K, Tojo A, Aoki N, Shibuya M: Characterization of the promoter region of the human c-kit proto-oncogene. Jpn J Cancer Res 84:1136, 1993
40. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335:835, 1988
41. Nicolaides NC, Gualdi R, Casadevall C, Manzella L, Calabretta B: Positive autoregulation of c-myb expression via Myb binding sites in the 5′ flanking region of the human c-myb gene. Mol Cell Biol 11:6166, 1991
42. Shore P, Sharrocks AD: The ETS-domain transcription factors Elk-1 and SAP-1 exhibit differential DNA binding specificities. Nucleic Acids Res 23:4698, 1995
43. Stenman G, Eriksson A, Claesson-Welsh L: Human PDGFA receptor gene maps to the same region on chromosome 4 as the KIT oncogene. Genes Chromosomes Cancer 1:155, 1989
44. Yasuda H, Galli SJ, Geissler EN: Cloning and functional analysis of the mouse c-kit promoter. Biochem Biophys Res Commun 191:893, 1993
45. Vandenbark GR, deCastro CM, Taylor H, Dew-Knight S, Kaufman RE: Cloning and structural analysis of the human c-kit gene. Oncogene 7:1259, 1992
46. Gewirtz AM, Calabretta B: Ac-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303, 1988
47. Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B: G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 245:180, 1989
48. Salmon P, Giovane A, Wasylyk B, Klatzmann D: Characterization of the human CD4 gene promoter: Transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins. Proc Natl Acad Sci USA 90:7739, 1993
49. Shapiro LH: Myb and Ets proteins cooperate to transactivate an early myeloid gene. J Biol Chem 270:8763, 1995
50. Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP: Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res 51:2897, 1991
51. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppressess apoptosis of human natural killer cells through the upreguation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
52. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Ratajczak M, Beran M, Gewirtz AM: Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88:2351, 1991
53. Ratajczak MZ, Hijiya N, Catani L, DeRiel K, Luger SM, McGlave P, Gewirtz AM: Acute-and chronic-phase chronic myelogenous leukemia colony-forming units are highly sensitive to the growth inhibitory effects of c-myb antisense oligodeoxynucleotides. Blood 79:1956, 1992
54. Reddy MA, Yang BS, Yue X, Barnett CJ, Ross IL, Sweet MJ, Hume DA, Ostrowski MC: Opposing actions of c-ets/PU.1 and c-myb protooncogene products in regulating the macrophage-specific promoters of the human and mouse colony-stimulating factor-1 receptor (c-fms) genes. J Exp Med 180:2309, 1994
55. Tsujimura T, Morii E, Nozaki M, Hashimoto K, Moriyama Y, Takebayashi K, Kondo T, Kanakura Y, Kitamura Y: Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice. Blood 88:1225, 1996